Abstract Background Advanced pancreatic cancer has a poor prognosis. and the current standard of care (gemcitabine based chemotherapy) provides a small survival advantage. However the drawback is the accompanying systemic toxicity. which targeted treatments may overcome. https://echobookmarks.com/story19493449/comparison-of-circulating-metabolite-concentrations-in-dogs-and-cats-when-allowed-to-freely-choose-macronutrient-intake